Thermal ablation was recommended as a treatment option for stage I NSCLC patients who have contraindications to surgery or radiotherapy, or be considered as a salvage treatment for patients who developed progression on EGFR or ALK therapy [6]. This evidence concerns the gene ALK and non-small cell lung carcinoma.